Digital SERS Nanoprobe Immunoassay With Single-Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples.

Published 04/08/2026

Research record: Digital SERS Nanoprobe Immunoassay With Single-Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples.

Published in Small Methods; first publication date 2026-04-08. PMID 41947704.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-04-08

Updated

2026-10-20

Disclaimer

professional use

References